Newsquawk Daily European Equity Opening News - 16th November 2026
Newsquawk Staff ·
ASIA
APAC stocks began the week on the back foot with most major indices in the red as participants digested disappointing data releases and await this week's key events, including Nvidia earnings on Tuesday and the Trump-Xi-Putin trilateral meeting on the sidelines of the APEC summit in Shenzhen on Thursday. ASX 200 trickled lower but with trade confined within tight parameters as the weakness in mining, materials and resources offset the gains in real estate, tech and telecoms. Nikkei 225 wiped out initial gains and fell beneath the 60,000 level as tech stocks led the declines, and with sentiment not helped by the disappointing preliminary GDP data for Q3, which showed a surprise annualised contraction of 0.1%. KOSPI underperformed with the index pressured by losses in its tech heavyweights. Hang Seng and Shanghai Comp were mixed, with the mainland pressured following disappointing Industrial Production and Retail Sales data, while lending figures released last Friday showed a contraction in New Loans. Conversely, Hong Kong bucked the trend and was led higher by consumer and EV stocks.
Chinese Activity Data - Retail Sales (Oct YY) 0.4% vs. Exp. 0.8% (Prev. 1.1%); Industrial Production (Oct YY) 4.8% vs. Exp. 5.3% (Prev. 5.5%); Fixed Asset Investment (YTD) (Oct YY) -8.1% vs. Exp. -7% (Prev. -7.2%).
Japanese Growth - GDP Growth Rate Prel (Q3 QQ) 0.0% vs. Exp. 0.1% (Prev. 0.4%); GDP Growth Annualised Prel (Q3) -0.1% vs. Exp. 0.3% (Prev. 1.4%).
Alibaba (9988 HK/BABA) - Co. launches Qwen4-Max, claiming performance comparable to Anthropic and OpenAI, with coding benchmarks reportedly outperforming Anthropic's Claude Fable 5.1 and Moonshot's Kimi K3.1 Pro. The model will remain closed-weight, although smaller versions are expected to be released soon.
SK Hynix (000660 KS) - Co. announces that it is to build a USD 650mln chip-testing fab and spend USD 1bln over five years to support chip suppliers, while it plans a jointly funded KRW 874.6bln testing facility in Yongin.
EUROPEAN CLOSES
CLOSES: Euro Stoxx 50 -0.16% at 6,389, Dax 40 -0.06% at 26,757, FTSE 100 +0.36% at 10,903, CAC 40 +0.09% at 8,369, FTSE MIB +0.10% at 51,859, IBEX 35 +0.27% at 20,020, PSI +1.06% at 9,698, SMI -0.29% at 15,106, AEX +0.07% at 1,141
SECTORS: Energy 1.60%, Utilities 1.13%, Consumer Stpl 1.08%, Telecoms 0.54%, Financials 0.14%, Healthcare -0.08%, Consumer Disc -0.54%, Materials -0.58%, Industrials -0.59%, IT -1.96%
FTSE 100
AstraZeneca (AZN LN) - Co. reportedly cut c. 600 jobs across its US respiratory and immunology commercial teams as part of efforts to reallocate resources towards its drug development pipeline, according to Bloomberg sources. Some affected employees were involved in marketing asthma treatments Breztri and Airsupra. Elsewhere, the US FDA approved perioperative Imfinzi in a novel regimen with neoadjuvant enfortumab vedotin for patients with muscle-invasive bladder cancer. (Bloomberg/AstraZeneca)
Barclays (BARC LN) - Co. is reportedly preparing to cut c. 200 investment banking jobs, primarily in New York and London, as early as Tuesday, according to Bloomberg sources. The reductions would be in addition to the c. 5,000 job cuts announced last month. (Bloomberg)
IG Group (IGG LN) - Co. is reportedly closing offices in France, Spain and Italy, with c. 50 jobs expected to be affected across Paris, Madrid and Milan, according to Bloomberg citing sources. (Bloomberg)
UK Energy - A group of Labour MPs is reportedly seeking to block approval for drilling at the Rosebank oil field in the North Sea, with 75 MPs signing a letter opposing the project and organisers hoping to secure up to 100 signatures, according to the Sunday Times citing sources. (Sunday Times) Of note for Equinor (EQNR NO) and Shell (SHEL LN)
UK Housing - Rightmove House Prices MM (Nov) -1.8% (Prev. 1.0%); Rightmove House Prices YY (Nov) -0.2% (Prev. -0.1%).
OTHER UK COMPANIES
BROKER MOVES
Travis Perkins (TPK LN) upgraded to Hold from Underperform at Jefferies
DAX
Uniper - Co. is reportedly nearing its first agreement to sell or lease a disused power plant site for data centre development, with advanced negotiations underway for two additional locations, according to the FT citing sources. (FT)
OTHER GERMAN COMPANIES
Evotec (EVT GY) - Co. secures a USD 2.9mln grant to advance early-stage drug safety testing using human stem cell technology. (Evotec)
BROKER MOVES
CAC
OTHER FRENCH COMPANIES
BROKER MOVES
PAN EUROPE
Centrica (CNA LN), Equinor (EQNR NO) - Cos. are reportedly among bidders advancing to the second round of the sale process for Germany's Uniper, according to Bloomberg citing sources. (Bloomberg)
Dutch Politics - Dutch PM Jetten's coalition government has avoided collapse after the centre-right People's Party temporarily withdrew its threat to leave the three-party alliance. (Bloomberg)
Stellantis (STLAM IM/STLAP FP) - Canadian Industry Minister Joly says the Co. owes the government hundreds of millions of dollars after failing to restart production at a plant near Toronto and instead agreeing to sell the facility, and the government is prepared to pursue legal action over an alleged breach of its funding agreement. (Newswires)
US-China Trade - The US and allies including Japan, Australia, Israel, the UK, South Korea, India, Qatar and the UAE have agreed to establish a joint list of critical AI technologies and supply chains requiring greater protection to counter China, under the San Francisco Declaration on the Secure Foundations of Enduring Prosperity. Germany, Sweden, the Netherlands and the European Commission are expected to sign next week, according to the FT. (FT)
Wolters Kluwer (WKL NA) - Co. agrees to acquire AgileMD for up to USD 100mln. (Wolters Kluwer)
BROKER MOVES
Generali (G IM) downgraded to Reduce from Add at AlphaValue
SMI
Novartis (NOVN SW) - Co. announces that it received a positive CHMP opinion of Cosentyx for adolescents aged 12 years and older with active moderate to severe hidradenitis suppurativa who have had an inadequate response to conventional systemic HS therapy. (Novartis)
Roche (ROP SW) - Co. announces that the US FDA has approved Gazyva/Gazyvaro for the treatment of adult patients with primary membranous nephropathy at risk of disease progression, to induce remission of proteinuria, after the trial met its primary endpoints. (Roche)
Sandoz (SDZ SW) - Co. announces the US launch of Enzeevu 2mg for the treatment of various retinal diseases. (Sandoz)
OTHER SWISS COMPANIES
BROKER MOVES
Geberit (GEBN SW) downgraded to Hold from Buy at Jefferies
Holcim (HOLN SW) upgraded to Buy from Hold at Jefferies
SCANDINAVIA
Novo Nordisk (NOVOB DC) - Co. reported positive Phase 3 Redefine 9 results for lower-dose CagriSema in overweight or obese adults. At week 68, doses of 1.7mg/1.7mg and 1.0mg/1.0mg achieved estimated average weight loss of 20.7% and 21.0%, respectively, versus 2.0% with placebo. Both doses also significantly reduced abdominal fat and increased the proportion achieving substantial weight loss. Separately, Novo Nordisk reported post hoc Phase 3 Redefine 1 analyses of CagriSema 2.4mg/2.4mg in adults with overweight or obesity. Early responders accounted for 67.8% of treated participants, achieving observed mean weight loss of 25.4% at week 68, versus 17.8% among delayed responders. Women were more likely to be early responders. Elsewhere, Novo presented real-world data from the Signal and Octane studies assessing reductions in food noise among adults with overweight or obesity taking Wegovy injections or pills. The Signal study found statistically significant reductions in unwanted thoughts about food within the first month of injectable semaglutide treatment, sustained through six months. (Novo Nordisk)
BROKER MOVES
Svenska Cellulosa AB (SCAB SS) downgraded to Sell from Neutral at Goldman Sachs
US
CLOSES: SPX -0.40% at 7,562, NDX -1.22% at 27,944, DJI +0.10% at 52,348, RUT -0.28% at 2,791
SECTORS: Technology -1.7%, Consumer Discretionary -0.45%, Industrials -0.42%, Materials -0.2%, Real Estate flat, Communication Services +0.26%, Utilities +0.4%, Health +0.56%, Financials +0.8%, Energy +0.96%, Consumer Staples +1.39%.
CVS Health (CVS) - CVS Health reported that GLP-1 users experienced better clinical outcomes, fewer hospitalisations and lower medical spending than comparable non-users. However, these savings did not fully offset higher pharmacy costs at current prices. The company highlighted targeted prescribing, sustained treatment and lower drug prices as key to improving affordability and overall healthcare value.
Eli Lilly (LLY) - Eli Lilly will present new cardiometabolic data at ObesityWeek 2026, held from 14th to 17th November 2026 in Washington, DC. Presentations will cover Phase 2 EloraTZP results, retatrutide and Zepbound, alongside posters on Foundayo and eloralintide. The programme includes clinical trial findings, patient-reported outcomes and real-world evidence.
Nvidia (NVDA) - Former Nvidia CEO Jensen Huang is considering a comeback as Silicon Valley allies lobby for his reinstatement following reports of affairs, including one with a suspected Chinese spy, the FT reported late Friday. Elon Musk (SPCX/TSLA) and Epic Games CEO Tim Sweeney support the campaign, while Nvidia's board investigates Huang's conduct. US Treasury Secretary Bessent urged Nvidia to appoint an external CEO following Huang's resignation, calling for a major leadership shake-up, the WSJ reports. Bessent questioned whether Nvidia knowingly facilitated restricted chip sales to China through Megaspeed, and demanded answers within 10 days. He favoured stronger enforcement of existing export controls over additional legislation.
Nvidia (NVDA) - Reuters on Friday reported that Huang allegedly misled company executives, including general counsel Tim Teter, about his affair with Megaspeed executive Alice Huang; internal correspondence shows Huang characterised their interactions as routine business dealings. He also discussed legal action against the NYT (NYT) over earlier coverage, but no lawsuit followed.
Megaspeed, Nvidia (NVDA) - Megaspeed said Alice Huang, whose reported relationship with former Nvidia CEO Jensen Huang has raised US national security concerns, left the company on 30th August 2025, and holds no current role, Reuters reports. The Singapore-based Nvidia partner denied allegations of improper business practices and said it had appointed external legal counsel to investigate compliance with US chip export controls.
What it means
Daily opening wraps of this kind aggregate the overnight drivers rather than constitute a single event; the tradable content is the calendar they frame. Here the week is anchored by Nvidia earnings and a Trump-Xi-Putin trilateral on the APEC sidelines, and the established pattern into a print of that weight is compressed ranges and reduced gross positioning, with the index-level reaction set by whether guidance clears the elevated bar rather than by the headline number. The China activity run, soft retail sales and industrial production alongside contracting new loans, fits the recurring sequence in which weak domestic-demand prints weigh on mining, materials and China-exposed cyclicals while leaving Hong Kong consumer and EV names to trade on idiosyncratic drivers, a split visible again in the Asia session. The sector closes on both sides of the Atlantic, staples, utilities and energy leading with IT at the bottom, are the classic defensive rotation signature that has preceded high-concentration event risk in past episodes of this kind. Japan's surprise annualised contraction in preliminary Q3 GDP carries the usual caveat that preliminary Japanese GDP is heavily revised, so the follow-on is the second estimate rather than the first print. The Nvidia governance strand is the genuinely unusual item: a former CEO lobbying to return while the Treasury Secretary publicly demands an external appointment and answers on export-control compliance has little precedent, and the transmission channel runs through licence enforcement and China chip exposure rather than through fundamentals, making official statements the tell to watch.
- [CALENDAR UPDATE] US President Trump will meet with Chinese President Xi on Thursday at 12:45 CST (04:45 GMT/23:45 EST) and will meet with Chinese President Xi and Russian President Putin at 14:30 CST (06:30 GMT/01:30 EST)
- China confirms that Chinese President Xi is to meet US President Trump and Russian President Putin in Shenzhen on Thursday, according to Xinhua
- Week in Focus – 16-20th November 2026: Highlights include: US Retail Sales, FOMC Minutes, Chinese Activity Data, PBoC LPR, RBA Minutes, UK Inflation and UK Jobs
- US Market Wrap: Tech leads losses; Hawkish Fed bets trimmed on soft headline PPI
- TREASURY WRAP: T-NOTE FUTURES (Z6) SETTLE 8 + TICKS LOWER AT 105-06
Related headlines
- CRUDE WRAP: WTI (Z6) SETTLES USD 0.18 LOWER AT USD 88.56/BBL; BRENT (F7) SETTLES USD 0.02 HIGHER AT USD 95.84/BBL2 days ago
- Ukrainian drone commander claims 750 Russian troops were killed on November 15th and 10,014 were killed between November 1st‑15th1 hour ago
- US Commerce Secretary Lutnick is expected to travel to China this week with President Trump2 hours ago
- US State Department says Secretary of State Rubio will join President Trump in the Philippines and China5 hours ago
- Lebanese sources say an Israeli tank shelled the outskirts of eastern Zawtar1 hour ago
- Russia downed 1,336 Ukrainian drones overnight, according to IFX1 hour ago
- US President Trump will hold a trilateral summit with Chinese President Xi and Russian President Putin next Thursday on the sidelines of the annual APEC conference, reports NYP citing sources2 days ago
- [MARKET ANALYSIS] DXY is little changed in muted FX trade to begin the week4 hours ago
- [MARKET ANALYSIS] Asia-Pac stocks are mostly lower to start the week after disappointing data from Japan and China, while participants also await key events this week, including Nvidia earnings and teh Trump-Xi-Putin trilateral meeting3 hours ago
- US FX WRAP: DXY rally continues in preferred haven bid; USD/JPYJPY again little changed2 days ago
- [MARKET ANALYSIS] Oil prices are contained despite Iran targeting an air base in Bahrain and the arrival of USS Roosevelt in CENTCOM's area of responsibility5 hours ago
- [MARKET ANALYSIS] T-note futures are little changed despite hawkish Fed rhetoric over the weekend4 hours ago
- Johnson & Johnson (JNJ) is eyeing an acquisition of Ollin Biosceinces for up to USD 3.4bn, according to FT7 hours ago
- PRE-MARKET JAPANESE AND SOUTH KOREAN STOCKS NEWS: Japanese megabank earnings updates7 hours ago
- [MARKET UPDATE] USD/JPY sharply falls from 159.90 to 159.55 2 days ago